halofantrine has been researched along with Disease Models, Animal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Abdel-Aal Sabra, AN; El-Lakkany, NM; Hammam, OA; Seif El-Din, SH | 1 |
Barratt, G; Grabe-GuimarĂ£es, A; GuimarĂ£es, HN; Leite, EA; Machado-Coelho, GL; Mosqueira, VC | 1 |
Ager, A; Andersen, SL; Berman, J; Ellis, W; Kuschner, R; McGreevy, P; Ohrt, C; Rossan, R; Schuster, BG; Wesche, D | 1 |
Schuster, BG; Wang, WX; Wesche, DL; Woosley, RL | 1 |
Puri, SK; Singh, N | 1 |
Batey, AJ; Coker, SJ | 1 |
1 review(s) available for halofantrine and Disease Models, Animal
Article | Year |
---|---|
Mechanism of cardiotoxicity of halofantrine.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Animals; Antimalarials; Cardiovascular Diseases; Cats; Child; Child, Preschool; Disease Models, Animal; Female; Heart Conduction System; Humans; Infant; Male; Middle Aged; Myocardium; Phenanthrenes | 2000 |
6 other study(ies) available for halofantrine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma mansoni in mice.
Topics: Animals; Anthelmintics; Disease Models, Animal; Drug Synergism; Female; Humans; Intestines; Ketoconazole; Liver; Male; Mice; Parasite Load; Phenanthrenes; Quinine; Schistosoma mansoni; Schistosomiasis mansoni; Treatment Outcome | 2013 |
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
Topics: Animals; Antimalarials; Bradycardia; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart; Hypotension; Lethal Dose 50; Long QT Syndrome; Malaria; Male; Mice; Nanocapsules; Phenanthrenes; Plasmodium berghei; Rats; Rats, Wistar | 2007 |
Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Artemisinins; Azithromycin; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Malaria; Malaria, Falciparum; Mice; Parasitemia; Phenanthrenes; Plasmodium berghei; Quinine; Sesquiterpenes | 1995 |
Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model.
Topics: Animals; Antimalarials; Cyproheptadine; Disease Models, Animal; Drug Resistance; Female; Male; Mice; Phenanthrenes; Plasmodium falciparum | 2000 |
Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.
Topics: Animals; Antimalarials; Disease Models, Animal; Electrocardiography; Histamine Antagonists; Male; Phenanthrenes; Potassium Channel Blockers; Quaternary Ammonium Compounds; Rabbits; Terfenadine; Torsades de Pointes | 2002 |